Clinical trial
Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty
NCT00485108 · Queen's University, Other · Completed
Key facts
| NCT number | NCT00485108 |
|---|---|
| Title | Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty |
| Official title | Anti-inflammatory Therapy Following Selective Laser Trabeculoplasty (SLT): A Randomized, Masked, Placebo Controlled Study |
| Lead sponsor | Queen's University, Other |
| Collaborators | Pfizer Industry Glaucoma Research Society of Canada |
| Status | Completed |
| Study type | Interventional |
| Conditions | Primary Open Angle Glaucoma, Pseudoexfoliation Glaucoma |
| Intervention type | Drug |
| Interventions | prednisolone 1%, ketorolac 0.5%, Artificial Tears (Methyl cellulose drops) |
| Enrollment | 120 |
| Start date | Jan 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Dec 1, 2014 |
| First posted | Jun 12, 2007 |
| Last update posted | Sep 23, 2015 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: